^
    BIOMARKER:

    KMT2D mutation + TMB-H

    i
    Other names: KMT2D, Lysine Methyltransferase 2D, Histone-Lysine N-Methyltransferase 2D, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 2, Lysine (K)-Specific Methyltransferase 2D, Trinucleotide Repeat Containing 21, Lysine N-Methyltransferase 2D, ALL1-Related Protein, MLL2, MLL4, ALR, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein, Histone-Lysine N-Methyltransferase MLL2, Truncated Lysine Methyltransferase 2D, Kabuki Mental Retardation Syndrome, Kabuki Make-Up Syndrome, CAGL114, KABUK1, TNRC21, AAD10, TMB |
    Entrez ID:
    8085
    Related biomarkers:
    Expression
    Mutation
    Others

    Associations

    Heatmap
    News
    Twitter
    Trials
    KMT2D mutation + TMB-H
    NSCLC
    PD-L1 inhibitor
    Sensitive: B - Late Trials
    KMT2D mutation + TMB-H
    NSCLC
    PD1 inhibitor + CTLA4 inhibitor
    Sensitive: B - Late Trials
    KMT2D mutation + TMB-H
    CRC
    Immunotherapy
    Sensitive: C3 – Early Trials